(Q53308405)
Statements
An open-label, phase I study of the polo-like kinase-1 inhibitor, BI 2536, in patients with advanced solid tumors. (English)
1 reference
1 reference
Elke Jäger
1 reference
Ralf-Dieter Hofheinz
1 reference
Salah-Eddin Al-Batran
1 reference
Volker L Reichardt
1 reference
Holger Fritsch
1 reference
Dirk Trommeshauser
1 reference
Gerd Munzert
1 reference
3 August 2010
1 reference
16
1 reference
4666-4674
1 reference
18
1 reference
Identifiers
1 reference